<DOC>
	<DOCNO>NCT00346853</DOCNO>
	<brief_summary>The purpose study investigate whether take 4-methylpyrazole ( 4-MP , fomepizole , Antizolâ„¢ ) inhibit dark adaptation eye . In word , test 4-MP slows process vitamin A derivatives eye . By slow process , individual Stargardt disease may better chance save remain vision . 4-MP show slow dark adaptation animal , FDA approve human use treat individual methanol ethylene glycol ( antifreeze ) poison shut body 's ability process alcohols . This medication excellent safety profile report short-term long-term side effect , long patient refrain alcohol medication body . A single dose 4-MP remains body 12 hour , therefore , may inhibit dark adaptation eye 12 hour . Studying effect 4-MP may lead effective medical treatment save Stargardt patient ' vision , may also similar effect macular degenerative disease .</brief_summary>
	<brief_title>Phase 1 Pilot Study 4-MP Treat Stargardt Macular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Corneal Dystrophies , Hereditary</mesh_term>
	<mesh_term>Fomepizole</mesh_term>
	<criteria>All nonpregnant , nonlactating adult normal vision eye Previous ocular pathology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Dark adaptation inhibition</keyword>
	<keyword>Stargardt macular dystrophy</keyword>
	<keyword>4-Methylpyrazole ( 4-MP )</keyword>
	<keyword>Antizol</keyword>
	<keyword>Fomepizole</keyword>
</DOC>